The START collaboration cluster aims to identify ‘at risk’ patients through novel imaging approaches. (iStock)
United against a killer: taking a strike at stroke
A new CSIRO collaboration research 'cluster' is poised to save countless lives by determining early indicators of stroke using biomarkers and the latest brain imaging technology. (7:03)
The player will show in this paragraph
After heart disease and cancer, stroke is the most common cause of death in Australia, and although the symptoms of a stroke may occur suddenly, the underlying conditions for it are usually present for years before a stroke occurs.
The START (STroke, imAging, pRevention and Treatment) cohort study will integrate imaging and biomarker analysis to identify patients at risk of stroke, and use these strategies in new preventative measures for these patients.
By studying 200 Australian acute ischaemic stroke victims (caused by an interruption of blood flow to the brain), the cohort’s activities will be centred on collecting information derived from brain imaging and blood samples with the aim of discovering and validating new diagnostic biomarkers to identify patients at risk of recurrent stroke and post stroke depression.
In this podcast Dr Cassandra Szoeke explains how identifying stroke biomarkers will greatly advance research to delay or prevent this debilitating medical condition.